Moreover, due to the smaller number of astrocytoma in this published cohort (n = 8), the cohort was analysed as a combined cohort of ‘LGG’, and the study showed no significant prognostic effect of TP53 mutation. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).